InsiderClue
← All stocks

CORCEPT THERAPEUTICS INC

CORT Mostly scheduled
CIK 0001088856 #827 in the set updated 17 Sep 2026
Bought (1 mo)
$0.00
out of their own pocket, the only kind of buying there is
Sold (1 mo)
$32.13M
$13.36M on a plan · $17.61M straight out of an exercise
Sold at will
$1.16M
1 of 23 sales
Net
−$32.13M
−$1.16M against sales at will

By person

14 insiders · 23 transactions
Insider
Role
Bought
Sold
Net
Holding
Of company
Worth
Change
MAHONEY DAVID L
Director
—
$12.25M (4) scheduled
−$12.25M
1,133,539
1.05%
$126.62M
−8.0%
Maduck Sean
See Remarks
—
$6.75M (5) scheduled
−$6.75M
53,938
0.0499%
$6.03M
+37.0%
Vieira Roberto Wandenkolk
President, Oncology
—
$6.46M (7) scheduled
−$6.46M
4,242
0.0039%
$473.85K
+4.3%
Park Kimberly
Director
—
$3.27M (1) scheduled
−$3.27M
0
0.0000%
$0.00
—
Robb Gary Charles
Chief Business Officer
—
$1.16M (1)
−$1.16M
108,666
0.1005%
$12.14M
+47.2%
Lyon Joseph Douglas
See Remarks
—
$1.13M (2) scheduled
−$1.13M
5,683
0.0053%
$634.81K
−42.6%
WILSON JAMES N
Director
—
$1.11M (3) scheduled
−$1.11M
2,539,086
2.35%
$283.63M
−22.8%
BELANOFF JOSEPH K
Chief Executive Officer
—
—
—
2,565,489
2.37%
$286.58M
−5.8%
BAKER G LEONARD JR
Director
—
—
—
2,241,893
2.07%
$250.43M
+12.0%
Hunt Hazel
Chief Scientific Officer
—
—
—
255,437
0.2363%
$28.53M
+115.4%
Mokari Atabak
Chief Financial Officer
—
—
—
16,304
0.0151%
$1.82M
+30.2%
Guyer William
Chief Development Officer
—
—
—
4,313
0.0040%
$481.78K
−25.6%
Swisher Daniel N JR
Director
—
—
—
0
0.0000%
$0.00
—
Cannon Gillian
Director
—
—
—
0
0.0000%
$0.00
—

Individual transactions

23
Insider
Date
Role
Action
Shares
Price
Amount
WILSON JAMES N
15 Sep 2026
Director
Sold on a plan indirect
2,800
$111.70
$312.77K
WILSON JAMES N
15 Sep 2026
Director
Sold on a plan indirect
400
$110.84
$44.33K
WILSON JAMES N
15 Sep 2026
Director
Sold on a plan indirect
6,800
$110.27
$749.83K
Lyon Joseph Douglas
14 Sep 2026
See Remarks
Sold after exercise
2,188
$114.12
$249.69K
Lyon Joseph Douglas
14 Sep 2026
See Remarks
Sold after exercise
7,812
$113.32
$885.26K
Vieira Roberto Wandenkolk
2 Sep 2026
President, Oncology
Sold after exercise
1,225
$115.44
$141.41K
Vieira Roberto Wandenkolk
2 Sep 2026
President, Oncology
Sold after exercise
5,621
$114.58
$644.04K
Vieira Roberto Wandenkolk
2 Sep 2026
President, Oncology
Sold after exercise
1,606
$113.72
$182.63K
Vieira Roberto Wandenkolk
2 Sep 2026
President, Oncology
Sold after exercise
974
$112.40
$109.47K
Vieira Roberto Wandenkolk
2 Sep 2026
President, Oncology
Sold after exercise
1,537
$111.37
$171.18K
Vieira Roberto Wandenkolk
2 Sep 2026
President, Oncology
Sold after exercise
23,770
$110.70
$2.63M
Vieira Roberto Wandenkolk
2 Sep 2026
President, Oncology
Sold after exercise
23,600
$109.35
$2.58M
Maduck Sean
1 Sep 2026
See Remarks
Sold after exercise
2,281
$115.61
$263.71K
Maduck Sean
1 Sep 2026
See Remarks
Sold after exercise
10,989
$114.71
$1.26M
Maduck Sean
1 Sep 2026
See Remarks
Sold after exercise
11,730
$113.94
$1.34M
Park Kimberly
26 Aug 2026
Director
Sold after exercise
26,685
$122.55
$3.27M
Maduck Sean
25 Aug 2026
See Remarks
Sold after exercise
5,870
$126.06
$739.97K
Maduck Sean
25 Aug 2026
See Remarks
Sold after exercise
25,085
$125.47
$3.15M
MAHONEY DAVID L
18 Aug 2026
Director
Sold on a plan indirect
400
$119.64
$47.86K
MAHONEY DAVID L
18 Aug 2026
Director
Sold on a plan indirect
7,055
$118.88
$838.71K
MAHONEY DAVID L
18 Aug 2026
Director
Sold on a plan indirect
91,167
$118.24
$10.78M
MAHONEY DAVID L
18 Aug 2026
Director
Sold on a plan indirect
4,984
$117.47
$585.48K
Robb Gary Charles
17 Aug 2026
Chief Business Officer
Sell indirect
10,000
$116.26
$1.16M

What was left out

Form 4 filings counted 14
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 7
Sales straight out of an exercise 15
Sales at will 1
Transactions with no price 0
Shares from compensation/vesting 159,980
History held since 9 Nov 2016